VC-1

VENTURE CAPITAL FIRM OF THE YEAR


This award recognises a European VC firm that has outperformed peers, created value and demonstrated truly outstanding investment decision making.

Qualifying criteria

- Open to venture capital firms only
- Firm must have more than 20% portfolio holdings in healthcare and/or life sciences companies
- Firms must have headquarters in Europe
- Period to be judged review is between 1 September 2018 and 1 September 2019

Judges will be paying particular attention to:

- Evidence of innovative company creation and deal-making strategies
- Volume of investments made in the qualifying timeline
- Number of lead investments made
- Number / quality of successful exits
- Number / value of new funds raised
- Fund performance and returns to LPs
 
 
 
BUY TICKETS AND TABLES
 
 

2019 FINALISTS

 

Arix Bioscience Plc

Arix Bioscience Plc, United Kingdom

Forbion

Forbion, The Netherlands

Gilde Healthcare

Gilde Healthcare, The Netherlands

HTGF

High-Tech Gründerfonds, Germany

LSP

LSP, The Netherlands

Medicxi

Medicxi, United Kingdom

Novo Seeds

Novo Seeds, Denmark

Seventure Partners

Seventure Partners, France

BUY TICKETS AND TABLES